Table 1.
Characteristics of patients on obtaining the sample analyzed.
| Patients (N = 50) | |
|---|---|
| Age (median years, IQR) | 43 (35–55) |
| Gender (N Male, %) | 42 (84) |
| HBV-DNA (median logIU/mL, IQR) | 5.9 (5.3–7.9) |
| HBV genotype A (N, %) D (N, %) F (N, %) |
|
| 39 (78) | |
| 8 (16) | |
| 3 (6) | |
| HBeAg-negative (N, %) | 33 (66) |
| ALT (median IU/L, IQR) | 80 (57–115) |
| Liver fibrosis 1 ≤F3 (%) >F3 (%) |
|
| 45 (90) | |
| 5 (10) | |
| Treatment history Previous NA (N, %) Previous IFN (N, %) |
|
| 17 (34) | |
| 2 (4) |
1 Ishak fibrosis stage (F), assessed by liver biopsy. Abbreviations: N indicates number; IQR, interquartile range; HBV, hepatitis B virus; IU, international units; HBeAg, hepatitis B e antigen; ALT, alanine aminotransferase; NA, nucleoside/nucleotide analogs; IFN, interferon.